We are pleased to share our recent review, a collaborative effort with Dr Keselowsky and our doctoral students Ying Li and Joshua Stewart, on the use of immunomodulatory materials in type 1 diabetes, This review highlights use of materials for both prevention and treatment of diabetes, from engineering vaccines to improving beta cell replacement.

Check out the paper here: Engineering immunomodulatory biomaterials for type 1 diabetes